MSN Laboratories initiates phase-III trial of Molnupiravir

Clinical trials will be performed on more than 2,400 subjects suffering from mild-to-moderate Covid-19

Comments

Popular posts from this blog

Viral video involving woman cop sparks controversy, plaint filed

Congress groomed me not to sit at home: Shivakumar

Infosys lays off hundreds after failing internal assessments in Mysuru